| The U.S. Food and Drug Administration has amended the emergency use authorization [EUA] for the Pfizer-BioNTech Covid-19 vaccine to “expand the use of a single booster dose to include use in individuals 12 through 15 years of age, shorten the time between the completion of primary vaccination of the Pfizer-BioNTech Covid-19 Vaccine and a booster dose […]
|